Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.39 | N/A |
| PEG Ratio (TTM) | 1.58 | N/A |
| P/S Ratio (TTM) | 0.85 | N/A |
| P/B Ratio (TTM) | 0.74 | N/A |
| P/FCF Ratio (TTM) | 22.97 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.29 | N/A |
| Price to 5YR AVG FCF Ratio | 18.18 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.46% | N/A |
| ROE (TTM) | 6.31% | N/A |
| Net Profit Margin (TTM) | 6.92% | N/A |
| ROIC 5YR AVG | 5.36% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 31.64% | 66.53% | 24.00% |
| Revenue | 17.98% | 14.98% | 10.15% |
| Net Income | 35.24% | 60.36% | 19.32% |
| Cash Flow | 1,960.93% | -0.66% | 5.44% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.00 | N/A |
| Quick Ratio (TTM) | 4.00 | N/A |
| D/E Ratio (TTM) | 1.26 | N/A |
| Interest Coverage (TTM) | 0.11 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.40 | N/A |
| LTL to 5YR AVG FCF | 29.60 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.44% | N/A |